Adaptive Biotechnologies Corporation
ADPTFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
179
Cost of Revenue
72
Gross Profit
107
Gross Margin
59.7%
Operating Income
-163
Operating Margin
-90.8%
Net Income
-159
Net Margin
-89.1%
EPS (Basic)
$-1.08
EPS (Diluted)
$-1.08
EBITDA
-129
EBITDA Margin
-71.9%
2023
12/31/2023
Revenue
170
Cost of Revenue
76
Gross Profit
95
Gross Margin
55.6%
Operating Income
-227
Operating Margin
-133.3%
Net Income
-225
Net Margin
-132.3%
EPS (Basic)
$-1.56
EPS (Diluted)
$-1.56
EBITDA
-189
EBITDA Margin
-111.2%
2022
12/31/2022
Revenue
185
Cost of Revenue
58
Gross Profit
127
Gross Margin
68.7%
Operating Income
-200
Operating Margin
-108.0%
Net Income
-200
Net Margin
-108.0%
EPS (Basic)
$-1.00
EPS (Diluted)
$-1.00
EBITDA
-175
EBITDA Margin
-94.6%
2021
12/31/2021
Revenue
154
Cost of Revenue
49
Gross Profit
105
Gross Margin
68.1%
Operating Income
-209
Operating Margin
-135.4%
Net Income
-207
Net Margin
-134.3%
EPS (Basic)
$-1.46
EPS (Diluted)
$-1.46
EBITDA
-193
EBITDA Margin
-125.3%
2020
12/31/2020
Revenue
98
Cost of Revenue
23
Gross Profit
76
Gross Margin
77.1%
Operating Income
-153
Operating Margin
-155.3%
Net Income
-146
Net Margin
-148.6%
EPS (Basic)
$-1.06
EPS (Diluted)
$-1.06
EBITDA
-144
EBITDA Margin
-146.7%